Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -63.58%1.18B | -31.45%800M | 84.64%-382M | -54.88%2.53B | -82.02%612M | 70.53%3.24B | 303.81%1.17B | -12,535.00%-2.49B | 30.18%5.61B | 272.32%3.4B |
| Net income from continuing operations | -11.93%1.45B | 7.25%976M | 4.34%1.25B | 10.41%4.34B | -25.16%589M | 39.12%1.64B | 4.96%910M | 9.32%1.2B | 8.38%3.93B | -30.54%787M |
| Operating gains losses | 64.07%-2.02B | 76.42%868M | -149.16%-1.23B | 102.77%129M | 129.58%2.75B | -185.52%-5.62B | -59.64%492M | 179.53%2.51B | -117.52%-4.66B | -1,783.70%-9.29B |
| Interest credited to policyholders’ deposits | -16.98%88M | -13.73%88M | -11.11%88M | -2.45%398M | -10.78%91M | -0.93%106M | 0.00%102M | 2.06%99M | 46.24%408M | 17.24%102M |
| Other non cash items | -161.60%-754M | -5,841.67%-713M | 49.64%-2.01B | -5,978.69%-3.59B | -143.54%-809M | 111.76%1.22B | 98.71%-12M | -176.25%-3.99B | 105.62%61M | 392.60%1.86B |
| Change in working capital | -56.11%2.66B | -195.83%-92M | 183.00%1.7B | -66.39%2.39B | -116.75%-1.72B | 197.07%6.06B | 116.55%96M | -155.46%-2.05B | 129.26%7.11B | 15,612.12%10.24B |
| -Change in loss and loss adjustment expense reserves | -20.00%80M | -16.67%85M | -13.13%86M | 18.73%393M | -4.17%92M | 13.64%100M | 34.21%102M | 39.44%99M | 117.76%331M | 92.00%96M |
| -Change in other working capital | -56.72%2.58B | -2,850.00%-177M | 175.16%1.61B | -70.54%2B | -117.82%-1.81B | 194.14%5.96B | 99.09%-6M | -159.28%-2.15B | 127.73%6.78B | 8,843.10%10.14B |
| Tax refund paid | -43.11%-239M | 22.33%-327M | 31.91%-175M | 8.23%-1.14B | -1.74%-293M | 44.52%-167M | -8.51%-421M | 2.28%-257M | -55.97%-1.24B | -83.44%-288M |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -63.58%1.18B | -31.45%800M | 84.64%-382M | -54.88%2.53B | -82.02%612M | 70.53%3.24B | 303.81%1.17B | -12,535.00%-2.49B | 30.18%5.61B | 272.32%3.4B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 42.67%-43M | 45.36%-53M | -600.00%-80M | 39.71%-337M | 24.90%-181M | 45.65%-75M | -251.56%-97M | 106.56%16M | 80.48%-559M | -91.27%-241M |
| Net PPE purchase and sale | -9.09%-36M | -23.08%-32M | 29.55%-31M | 16.86%-143M | -150.00%-40M | 28.26%-33M | 38.10%-26M | 35.29%-44M | -342.25%-172M | 60.98%-16M |
| Net business purchase and sale | 1,300.00%28M | 200.00%3M | -33.33%2M | 92.17%-17M | 89.64%-23M | 106.25%2M | -99.41%1M | 102.27%3M | 91.97%-217M | -1,918.18%-222M |
| Dividends received (cash flow from investment activities) | 157.89%49M | -70.00%6M | --0 | 400.00%160M | --0 | 111.11%19M | -13.04%20M | --121M | 18.52%32M | --0 |
| Net other investing changes | -33.33%-84M | 67.39%-30M | 20.31%-51M | -66.83%-337M | -3,833.33%-118M | 8.70%-63M | -6.98%-92M | -45.45%-64M | 22.01%-202M | 95.95%-3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 42.67%-43M | 45.36%-53M | -600.00%-80M | 39.71%-337M | 24.90%-181M | 45.65%-75M | -251.56%-97M | 106.56%16M | 80.48%-559M | -91.27%-241M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 99.39%-10M | -193.88%-864M | -77.51%-1.64B | -25.79%-3.88B | -59.47%-1.02B | -15.21%-1.64B | 61.11%-294M | -250.38%-925M | -4,246.48%-3.09B | 16.47%-639M |
| Net issuance payments of debt | 203.22%961M | -71.50%177M | -422.94%-570M | 18.69%-496M | -450.00%-77M | -30.94%-931M | 474.10%621M | -144.49%-109M | -132.76%-610M | 109.61%22M |
| Net common stock issuance | -171.92%-397M | -39.16%-398M | -198.85%-520M | -359.68%-855M | ---249M | 21.51%-146M | ---286M | ---174M | ---186M | --0 |
| Cash dividends paid | -4.97%-507M | -4.78%-526M | -4.07%-486M | -4.25%-1.96B | 2.11%-510M | -6.62%-483M | -6.36%-502M | -7.11%-467M | -12.63%-1.88B | -20.32%-521M |
| Proceeds from stock option exercised by employees | -62.50%3M | --19M | -54.55%5M | -12.24%43M | 50.00%24M | -11.11%8M | --0 | -45.00%11M | 716.67%49M | 433.33%16M |
| Interest paid (cash flow from financing activities) | 23.68%-58M | -9.35%-117M | 24.10%-63M | 3.95%-389M | -2.50%-123M | 11.63%-76M | 9.32%-107M | -2.47%-83M | -50.00%-405M | -13.21%-120M |
| Net other financing charges | 25.00%-12M | 5.00%-19M | 92.23%-8M | -328.85%-223M | -133.33%-84M | ---16M | -400.00%-20M | -758.33%-103M | -2,700.00%-52M | ---36M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 99.39%-10M | -193.88%-864M | -77.51%-1.64B | -25.79%-3.88B | -59.47%-1.02B | -15.21%-1.64B | 61.11%-294M | -250.38%-925M | -4,246.48%-3.09B | 16.47%-639M |
| Net cash flow | ||||||||||
| Beginning cash position | -14.08%7.5B | -0.49%7.87B | -10.89%9.95B | 19.18%11.17B | 14.22%10.21B | 4.26%8.73B | -10.65%7.91B | 19.18%11.17B | 21.83%9.37B | -4.89%8.94B |
| Current changes in cash | -25.90%1.13B | -115.08%-117M | 38.04%-2.1B | -185.77%-1.69B | -123.31%-588M | 354.03%1.52B | 292.56%776M | -595.90%-3.4B | 42.85%1.97B | 10,869.57%2.52B |
| Effect of exchange rate changes | 375.56%124M | -631.91%-250M | -85.82%19M | 378.70%471M | 215.92%335M | -119.82%-45M | 163.51%47M | 506.06%134M | -155.96%-169M | -528.26%-289M |
| End cash Position | -14.25%8.75B | -14.08%7.5B | -0.49%7.87B | -10.89%9.95B | -10.89%9.95B | 14.22%10.21B | 4.26%8.73B | -10.65%7.91B | 19.18%11.17B | 19.18%11.17B |
| Free cash flow | -64.33%1.14B | -32.69%768M | 83.68%-413M | -56.08%2.39B | -83.11%572M | 72.98%3.21B | 361.94%1.14B | -5,172.92%-2.53B | 26.19%5.44B | 270.57%3.39B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.